BioPharmX Corp fka BPMX

[Whos_Who]

BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 5, 2017 – BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced that Anja Krammer, president and co-founder of BioPharmX, will present at the Rodman & Renshaw 19th Annual Global Investment Conference next week.

Ms. Krammer is scheduled to present on September 12 from 3:25 – 3:50 p.m. EDT in the Louis Room at the Lotte New York Palace Hotel. A live webcast of the presentation will be available at
http://www.wsw.com/webcast/rrshq27/bpmx and will be archived for 90 days following the presentation.

The Rodman & Renshaw 19th Annual Global Investment Conference hosts approximately 200 public and private companies presenting to an audience of approximately 2,000 attendees. The conference focuses on tracks dedicated to healthcare, natural resources, technology, media and telecommunications, and cleantech.